Publications - Supplemental material
Please find below supplemental material corresponding to publications of our group. Currently, we list 133 supplements.
If you have problems accessing electronic information, please let us know:
You may use this URL to cite or link to us.
©NOTICE: All documents are copyrighted by the authors; If you would like to use all or a portion of any paper, please contact the author.
This supplement is also available at http://www.bioinf.uni-leipzig.de/publications/supplements/21-002You may use this URL to cite or link to us.
BIOINF 21-002: Early childhood metabolome can reveal BMI tendency at the age of 8
Stephanie Kehr, Ulrike Rolle-Kampczyk, Stefan Röder, Wolfgang Otto, Gunda Herberth, Ana Zenclussen, Peter F. Stadler, Martin von Bergen
>
>
PreProcess
age0 | age1 | age2 | age3 | age4 | age8 | age10 | |
---|---|---|---|---|---|---|---|
FA | 250 | 221 | 49 | 187 | 239 | - | - |
female | 119 | 109 | 24 | 93 | 118 | - | - |
male | 131 | 109 | 25 | 94 | 118 | - | - |
BMI_z | 0 | 216 | 49 | 181 | 234 | 663 | 559 |
CV | 36.66 | 37.425 | 27.18 | 33.9 | 27.14 | 44.49 | - |
AA | 305 | 92 | 147 | 156 | 144 | - | - |
female | 150 | 46 | 64 | 79 | 72 | - | - |
male | 155 | 46 | 83 | 76 | 70 | - | - |
BMI_z | 0 | 92 | 145 | 147 | 141 | 482 | 411 |
CV | 31.8 | 28.15 | 28.95 | 29.32 | 24.065 | 39.08 | - |
Discriminant Analysis
Age PLS-DA
Metabolite Dynamics
Age Trajectories
- Lyso-glycerophospholipids
- - lysoPC.a.C16.0: [pdf]
- - lysoPC.a.C16.1: [pdf]
- - lysoPC.a.C17.0: [pdf]
- - lysoPC.a.C18.0: [pdf]
- - lysoPC.a.C18.1: [pdf]
- - lysoPC.a.C18.2: [pdf]
- - lysoPC.a.C20.3: [pdf]
- - lysoPC.a.C20.4: [pdf]
- - lysoPC.a.C24.0: [pdf]
- - lysoPC.a.C26.0: [pdf]
- - lysoPC.a.C26.1: [pdf]
- - lysoPC.a.C28.0: [pdf]
- - lysoPC.a.C28.1: [pdf]
- Glycerophospholipids diacyl
- - PC.aa.C24.0: [pdf]
- - PC.aa.C28.1: [pdf]
- - PC.aa.C30.0: [pdf]
- - PC.aa.C32.0: [pdf]
- - PC.aa.C32.1: [pdf]
- - PC.aa.C32.2: [pdf]
- - PC.aa.C32.3: [pdf]
- - PC.aa.C34.1: [pdf]
- - PC.aa.C34.2: [pdf]
- - PC.aa.C34.3: [pdf]
- - PC.aa.C34.4: [pdf]
- - PC.aa.C36.0: [pdf]
- - PC.aa.C36.1: [pdf]
- - PC.aa.C36.2: [pdf]
- - PC.aa.C36.3: [pdf]
- - PC.aa.C36.4: [pdf]
- - PC.aa.C36.5: [pdf]
- - PC.aa.C36.6: [pdf]
- - PC.aa.C38.0: [pdf]
- - PC.aa.C38.1: [pdf]
- - PC.aa.C38.3: [pdf]
- - PC.aa.C38.4: [pdf]
- - PC.aa.C38.5: [pdf]
- - PC.aa.C38.6: [pdf]
- - PC.aa.C40.2: [pdf]
- - PC.aa.C40.3: [pdf]
- - PC.aa.C40.4: [pdf]
- - PC.aa.C40.5: [pdf]
- - PC.aa.C40.6: [pdf]
- - PC.aa.C42.0: [pdf]
- - PC.aa.C42.1: [pdf]
- - PC.aa.C42.2: [pdf]
- - PC.aa.C42.4: [pdf]
- - PC.aa.C42.5: [pdf]
- - PC.aa.C42.6: [pdf]
- Glycerophospholipids acyl-alkyl
- - PC.ae.C30.0: [pdf]
- - PC.ae.C30.1: [pdf]
- - PC.ae.C30.2: [pdf]
- - PC.ae.C32.1: [pdf]
- - PC.ae.C32.2: [pdf]
- - PC.ae.C34.0: [pdf]
- - PC.ae.C34.1: [pdf]
- - PC.ae.C34.2: [pdf]
- - PC.ae.C34.3: [pdf]
- - PC.ae.C36.0: [pdf]
- - PC.ae.C36.1: [pdf]
- - PC.ae.C36.2: [pdf]
- - PC.ae.C36.3: [pdf]
- - PC.ae.C36.4: [pdf]
- - PC.ae.C36.5: [pdf]
- - PC.ae.C38.0: [pdf]
- - PC.ae.C38.1: [pdf]
- - PC.ae.C38.2: [pdf]
- - PC.ae.C38.3: [pdf]
- - PC.ae.C38.4: [pdf]
- - PC.ae.C38.5: [pdf]
- - PC.ae.C38.6: [pdf]
- - PC.ae.C40.1: [pdf]
- - PC.ae.C40.2: [pdf]
- - PC.ae.C40.3: [pdf]
- - PC.ae.C40.4: [pdf]
- - PC.ae.C40.5: [pdf]
- - PC.ae.C40.6: [pdf]
- - PC.ae.C42.1: [pdf]
- - PC.ae.C42.2: [pdf]
- - PC.ae.C42.3: [pdf]
- - PC.ae.C42.4: [pdf]
- - PC.ae.C42.5: [pdf]
- - PC.ae.C44.3: [pdf]
- - PC.ae.C44.4: [pdf]
- - PC.ae.C44.5: [pdf]
- - PC.ae.C44.6: [pdf]
- Sphinglipids
- - SM.C16.0: [pdf]
- - SM.C16.1: [pdf]
- - SM.C18.0: [pdf]
- - SM.C18.1: [pdf]
- - SM.C20.2: [pdf]
- - SM.C22.3: [pdf]
- - SM.C24.0: [pdf]
- - SM.C24.1: [pdf]
- - SM.C26.0: [pdf]
- - SM.C26.1: [pdf]
- - SM..OH..C14.1: [pdf]
- - SM..OH..C16.1: [pdf]
- - SM..OH..C22.1: [pdf]
- - SM..OH..C22.2: [pdf]
- - SM..OH..C24.1: [pdf]
- AminoAcids
- - Ala: [pdf]
- - Arg: [pdf]
- - Asn: [pdf]
- - Asp: [pdf]
- - Cit: [pdf]
- - Gln: [pdf]
- - Glu: [pdf]
- - Gly: [pdf]
- - His: [pdf]
- - Ile: [pdf]
- - Leu: [pdf]
- - Lys: [pdf]
- - Met: [pdf]
- - Orn: [pdf]
- - Phe: [pdf]
- - Pro: [pdf]
- - Ser: [pdf]
- - Thr: [pdf]
- - Trp: [pdf]
- - Tyr: [pdf]
- - Val: [pdf]
- Biogenic Amines
- - AAA: [pdf]
- - ADMA: [pdf]
- - alpha.AAA: [pdf]
- - BCAA: [pdf]
- - Creatinine: [pdf]
- - Kynurenine: [pdf]
- - Sarcosine: [pdf]
- - Serotonin: [pdf]
Correlation Networks
- Newborn
- [Age0]
- Age1
- [Age1]
- Age2
- [Age2]
- Age3
- [Age3]
- Age4
- [Age4]
- Age1-Age4
- [BMI_z-BMI_z8]
- Differential Networks
- [All to Age0]
- [All to Age4]
- [Age1-Age3 to Age4]
BMI correlation
- Age1
- [BMI_z1-BMI_z8]
- Age2
- [BMI_z2-BMI_z8]
- Age3
- [BMI_z3-BMI_z8]
- Age4
- [BMI_z4-BMI_z8]
- Age1-Age4
- [BMI_z-BMI_z8]
Sublipids sPLS-DA
- lysoGlycerophospholipids
- [lysoGlycerophospholipids]
- [Loadings]
- Glycerophospholipids
- [Glycerophospholipids]
- [Loadings]
- Shinglipids
- [Sphinglipids]
- [Loadings]
Diffential Trajectories Normal and Overweight and Obese
- Lyso-glycerophospholipids
- - lysoPC.a.C16.0: [pdf]
- - lysoPC.a.C16.1: [pdf]
- - lysoPC.a.C17.0: [pdf]
- - lysoPC.a.C18.0: [pdf]
- - lysoPC.a.C18.1: [pdf]
- - lysoPC.a.C18.2: [pdf]
- - lysoPC.a.C20.3: [pdf]
- - lysoPC.a.C20.4: [pdf]
- - lysoPC.a.C24.0: [pdf]
- - lysoPC.a.C26.0: [pdf]
- - lysoPC.a.C26.1: [pdf]
- - lysoPC.a.C28.0: [pdf]
- - lysoPC.a.C28.1: [pdf]
- Glycerophospholipids diacyl
- - PC.aa.C24.0: [pdf]
- - PC.aa.C28.1: [pdf]
- - PC.aa.C30.0: [pdf]
- - PC.aa.C32.0: [pdf]
- - PC.aa.C32.1: [pdf]
- - PC.aa.C32.2: [pdf]
- - PC.aa.C32.3: [pdf]
- - PC.aa.C34.1: [pdf]
- - PC.aa.C34.2: [pdf]
- - PC.aa.C34.3: [pdf]
- - PC.aa.C34.4: [pdf]
- - PC.aa.C36.0: [pdf]
- - PC.aa.C36.1: [pdf]
- - PC.aa.C36.2: [pdf]
- - PC.aa.C36.3: [pdf]
- - PC.aa.C36.4: [pdf]
- - PC.aa.C36.5: [pdf]
- - PC.aa.C36.6: [pdf]
- - PC.aa.C38.0: [pdf]
- - PC.aa.C38.1: [pdf]
- - PC.aa.C38.3: [pdf]
- - PC.aa.C38.4: [pdf]
- - PC.aa.C38.5: [pdf]
- - PC.aa.C38.6: [pdf]
- - PC.aa.C40.2: [pdf]
- - PC.aa.C40.3: [pdf]
- - PC.aa.C40.4: [pdf]
- - PC.aa.C40.5: [pdf]
- - PC.aa.C40.6: [pdf]
- - PC.aa.C42.0: [pdf]
- - PC.aa.C42.1: [pdf]
- - PC.aa.C42.2: [pdf]
- - PC.aa.C42.4: [pdf]
- - PC.aa.C42.5: [pdf]
- - PC.aa.C42.6: [pdf]
- Glycerophospholipids acyl-alkyl
- - PC.ae.C30.0: [pdf]
- - PC.ae.C30.1: [pdf]
- - PC.ae.C30.2: [pdf]
- - PC.ae.C32.1: [pdf]
- - PC.ae.C32.2: [pdf]
- - PC.ae.C34.0: [pdf]
- - PC.ae.C34.1: [pdf]
- - PC.ae.C34.2: [pdf]
- - PC.ae.C34.3: [pdf]
- - PC.ae.C36.0: [pdf]
- - PC.ae.C36.1: [pdf]
- - PC.ae.C36.2: [pdf]
- - PC.ae.C36.3: [pdf]
- - PC.ae.C36.4: [pdf]
- - PC.ae.C36.5: [pdf]
- - PC.ae.C38.0: [pdf]
- - PC.ae.C38.1: [pdf]
- - PC.ae.C38.2: [pdf]
- - PC.ae.C38.3: [pdf]
- - PC.ae.C38.4: [pdf]
- - PC.ae.C38.5: [pdf]
- - PC.ae.C38.6: [pdf]
- - PC.ae.C40.1: [pdf]
- - PC.ae.C40.2: [pdf]
- - PC.ae.C40.3: [pdf]
- - PC.ae.C40.4: [pdf]
- - PC.ae.C40.5: [pdf]
- - PC.ae.C40.6: [pdf]
- - PC.ae.C42.1: [pdf]
- - PC.ae.C42.2: [pdf]
- - PC.ae.C42.3: [pdf]
- - PC.ae.C42.4: [pdf]
- - PC.ae.C42.5: [pdf]
- - PC.ae.C44.3: [pdf]
- - PC.ae.C44.4: [pdf]
- - PC.ae.C44.5: [pdf]
- - PC.ae.C44.6: [pdf]
- Sphinglipids
- - SM.C16.0: [pdf]
- - SM.C16.1: [pdf]
- - SM.C18.0: [pdf]
- - SM.C18.1: [pdf]
- - SM.C20.2: [pdf]
- - SM.C22.3: [pdf]
- - SM.C24.0: [pdf]
- - SM.C24.1: [pdf]
- - SM.C26.0: [pdf]
- - SM.C26.1: [pdf]
- - SM..OH..C14.1: [pdf]
- - SM..OH..C16.1: [pdf]
- - SM..OH..C22.1: [pdf]
- - SM..OH..C22.2: [pdf]
- - SM..OH..C24.1: [pdf]
- Sugar
- - H1: [pdf]